Seref Alpsoy Selected Research

Seref Alpsoy Research Topics

4	Hypertension (High Blood Pressure) 01/2021 - 01/2013
3	Atherosclerosis 01/2021 - 08/2014
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2015 - 05/2013
2	Hemorrhage 01/2022 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2018 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2015 - 02/2015
2	Cardiotoxicity 06/2014 - 03/2013
1	Hypoxia (Hypoxemia) 08/2022
1	Acute Coronary Syndrome 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Fibrosis (Cirrhosis) 12/2018
1	Peripheral Arterial Disease 10/2018
1	Inflammation (Inflammations) 10/2018
1	White Coat Hypertension 06/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2015
1	Apnea 08/2014
1	Carotid Artery Diseases 08/2014
1	Obstructive Sleep Apnea 08/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Insulin Resistance 07/2013
1	Vascular Diseases (Vascular Disease) 05/2013
1	Hyperthyroidism 01/2013
1	Mental Disorders (Mental Disorder) 01/2013
1	Hypothyroidism 01/2013

3	alpha-2-HS-GlycoproteinIBA 08/2014 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 02/2015
2	AntioxidantsIBA 06/2014 - 03/2013
1	endothelial PAS domain-containing protein 1IBA 08/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 08/2022
1	beta-Globins (beta Globin)IBA 08/2022
1	antineoplaston A10 (A 10)IBA 01/2021
1	MyokinesIBA 01/2021
1	Galectin 3 (LGALS3)IBA 12/2018
1	CytokinesIBA 10/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Vitamin D FDA LinkGeneric 06/2016
1	1-nitroso-5,6-dihydrothymineIBA 06/2015
1	OsteoprotegerinIBA 05/2015
1	CadmiumIBA 06/2014
1	C-Reactive ProteinIBA 01/2014
1	Hormones (Hormone)IBA 07/2013
1	Glycoproteins (Glycoprotein)IBA 07/2013
1	Blood Proteins (Serum Proteins)IBA 07/2013
1	HomocysteineIBA 05/2013
1	CopperIBA 05/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	Antihypertensive Agents (Antihypertensives)IBA 01/2013

1	Length of Stay 01/2022